Charlotte is senior director, business development & strategic alliances at NanoString.
Journey to Madrona
Charlotte has over fifteen years of basic science research and over ten years of biotech venture investment experience across a broad range of sectors, therapeutic modalities, and stages. Charlotte has a proven ability to combine deep scientific expertise and business development acumen to identify innovative opportunities to drive returns and impact.
Prior to NanoString, Charlotte was partner and head of Gates Foundation Venture Capital, a $500M initiative at the Bill and Melinda Gates Foundation Strategic Investment Fund, where she oversaw investing in innovative technologies that supported the foundation’s programs in global health and agriculture. Notably, Charlotte led investments and served on the board of directors of Synlogic (Nasdaq: SYBX), Sera Prognostics, Lodo Therapeutics, Agtech Accelerator, Vedanta, and Vir Biotechnology (Nasdaq: VIR). Before joining the foundation, Charlotte was a vice president at H.I.G. BioVentures, investing broadly in healthcare. Charlotte began her career in early-stage biotech, investing at Accelerator Corporation, where she was part of the founding team and oversaw the management of several companies. Charlotte earned a bachelor’s in microbiology from the University of Washington and a Ph.D. in pharmacology and cancer biology from Duke University, for which she received the prestigious Harold Weintraub Award. She did her post-doctoral work in stem cells and regenerative medicine at the Institute for Stem Cells and Regenerative Medicine at UW.
Lesson learned
If you are the smartest person in the room, you’re not doing it right.
When she’s not in the office…
Charlotte enjoys spending time with her family and working on various music projects. She is an avid disaster film and book fan, so if you have a world-ending story, she wants to hear about it.
Noteworthy
Charlotte currently serves on the Board of Directors at City of Hope and Nuvara Health, and she was honored as a Fierce Woman in Biopharma 2016 by FiercePharma, and as a Leading Woman in Life Sciences 2016 by Life Science Washington. She is a member of the Kauffman Society of Fellows (Class 14) and has served on the board of Life Science Washington and the steering committees of the Fred Hutch Cancer Institute’s Evergreen Fund, UW Innovation Roundtable, and Columbia University Lab-to-Market initiative.